Highlights
A collection of news and information related to Bristol Myers Squibb Company published by this site and its partners.
Displaying items 1-12 of 40
» View ktuu.com items only
1
2
3
4
•
Next >
-
Princeton: Toyota Marks 10 Years in Midwest
KickingTiresBy Eamonn Brennan Cars.com It's been 10 years since Toyota opened its plant on farmland just south of Princeton, and Gibson County residents have rallied around the site. Its residents have united around the new jobs, competitive salaries and endless........Tags: Plant Openings, Economic Policy, Politics, Toyota Motor Corp., Heavy Engineering
-
Lazarus: Patients' choices narrower, yet cost of insurance rises
It's hard enough having a serious condition like cancer or kidney failure. It's even worse, some might think, when your health insurer says you have to buy your medicine from the pharmacy of its choice — or pay the full amount for expensive life-...Tags: HIV, Drugs and Medicines, Healthcare Provider, Chemical Industry, Employment Opportunities
-
Assemblyman Hall attended Kentucky Derby as fact-finder, fundraiser
PolitiCalAssemblyman Isadore Hall III (D-Compton) takes fact-finding trip to Kentucky Derby. He said taxpayers did not pay for his trip and he did not bet on a horse.... -
AIDS charity sues Bristol Myers, saying it overcharged for medication [Updated]
Money & CompanyAIDS charity says Bristol Myers overcharged for medication.... -
Plavix advertising indirectly cost taxpayers an extra $207 million over five years*
Booster ShotsAdvertising brand-name prescription medications directly to patients is a uniquely American custom, and a controversial one at that. A study published today in the Archives of Internal Medicine may stir new debate over the practice. In the case of one....... -
Earnings roundup: Lockheed, Bristol-Myers, 3M, Estee Lauder and more
Money & CompanySeveral major companies reported mixed but generally strong quarterly earnings this morning. Some, like Bristol-Myers Squibb Co., reported soaring profits, and others posted losses that were smaller than expected. Lockheed Martin Corp., the world’s... -
Old HIV drug found to produce rare liver problem, FDA says
Booster ShotsDidanosine, the second drug approved for the treatment of HIV infections and one of the oldest weapons in the AIDS armamentarium, has been found to produce rare cases of potentially fatal liver disease in patients taking it for long periods,...... -
LETTER: ALEC too far right for these groups
The American Legislative Exchange Council (ALEC) is a group promoting far-right legislation. Its tax exempt status is currently challenged, as its sole purpose is to formulate legislation promoting extremely conservative points of view and helping the...Tags: Environmental Issues, Merck & Company Incorporated, Reed Elsevier, Renewable Energy, Deere and Company
-
New CEO to lead change microloan non-profit
Inside the John Hancock Center, 13 floors up, Vicki Escarra gazes into a large camera lens. She eschews a word-for-word script, speaking instead from an outline that allows for more spontaneity. "You know, women are the largest untapped lever in the...
Tags: Uganda, Travel, Human Interest, Religion and Belief, Feeding America
-
Developer unveils $50 million office complex
A developer on Wednesday unveiled detailed plans for a $50 million office complex that would include a 570-space underground parking garage and could attract more than 700 mostly white-collar office workers to downtown Allentown.
One City Center, to be...Tags: Property, Finance, Rental Service, Realty, Economy, Business and Finance
-
Use of atypical antipsychotics for lesser disorders is gaining ground, despite safety concerns
Los Angeles Times Staff WriterAbout a year ago, patients began trooping into the office of UCLA psychiatrist Andrew Leuchter, asking whether an antipsychotic drug called Abilify "might be right for them." Few appeared to be delusional, plagued by hallucinations or suffering fearsome...Tags: Death, Research, Symptoms, Drugs and Medicines, Yale University
-
GlaxoSmithKline to acquire Human Genome Sciences
After spurning a hostile takeover bid from GlaxoSmithKline PLC in April, Human Genome Sciences Inc. said Monday it agreed to be bought by the biopharmaceutical giant for a more lucrative offer valued at $3.6 billion.
GlaxoSmithKline boosted its offer for...Tags: Rockville (Bethlehem, Pennsylvania), Drugs and Medicines, Companies and Corporations, Chemical Industry, Science and Technology
Aug 1, 2008
|Blog| Cars.com
Nov 30, 2012
|Column| Los Angeles Times
May 11, 2012
| Los Angeles Times
Nov 29, 2010
| Los Angeles Times
Nov 23, 2009
| Los Angeles Times
Jan 28, 2010
| Los Angeles Times
Feb 1, 2010
| Los Angeles Times
Apr 29, 2013
|Story| Aberdeen News
Apr 15, 2013
|Story| Chicago Tribune
Dec 14, 2011
|Story| Allentown Morning Call
Apr 13, 2009
|Story| Los Angeles Times
Jul 16, 2012
|Story| Baltimore Sun
Original site for Bristol Myers Squibb Company topic gallery.
